MRI test to measure liver scar severity in Cushing’s
Part of Hormones & metabolism clinical trials.
This study uses a special MRI scan to measure how severe liver scarring is. It focuses on people with Cushing’s syndrome or suspected Cushing’s, or those with metabolic syndrome, to see how well the scan helps diagnose and assess severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Have (or be eligible for) French social security coverage
- Have Cushing’s syndrome, suspected Cushing’s, or metabolic syndrome
- Have had key blood testing for suspected Cushing’s (dexamethasone suppression with an 8am cortisol result in the last 3 months)
- Be able to safely have an MRI scan (no MRI contraindications) and your body shape allows scanning
- Not be pregnant or, if you could become pregnant, use reliable birth control
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether NAC (a supplement/medicine) can improve liver health in adults who have active Cushing’s syndrome and fatty liver disease. It may help if your excess stress hormone levels are affecting your liver.
This study tests whether a special MRI scan (called 4D-MRI) can identify liver scarring or damage. It may help doctors measure liver fibrosis and inflammation without relying only on invasive tests.
This study uses advanced MRI scans to get a clearer picture of liver fat, inflammation, and scarring in people with chronic liver disease. It aims to help doctors diagnose and understand liver problems better.
This study tests whether a special 3D MRI scan (3D-MRE) can measure liver scarring and the high pressure in the liver called portal hypertension. It may help your team use imaging to understand how severe your liver disease is, especially when a pressure test (HVPG) is being considered.
This trial uses a special MRI scan (called MRE) to measure liver stiffness after surgery. The results may help predict if the edge of the removed tumor still has cancer cells and if the cancer might come back.
This trial uses a special MRI scan called 3D magnetic resonance elastography to measure liver stiffness before liver surgery. The goal is to see if this test can help predict surgical risk and outcomes for people with liver cancer or liver metastases.
Hear when a new Cushing Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.